🔎 Trials Near Me

Akèy › Timè Wilms › Distrik Columbia › Washington

Etid klinik pou Timè Wilms nan Washington, DC

7 etid pou Timè Wilms ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Ap rekriteFaz 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
Jiska laj 30 · Tout sèks · Mizajou Aug 25, 2026 · NCT04322318

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Ap rekriteFaz 1
  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Laj 1 a 23 · Tout sèks · Mizajou Aug 13, 2026 · NCT07172958

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Ap rekriteFaz 2
  • Children's National Hospital (Data Collection Only), Washington D.C.
12 Months · Tout sèks · Mizajou May 6, 2026 · NCT05985161

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Etid Timè Wilms nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.